TABLE 1

Results of Zika NS1-based ELISA from 63 travelers with neutralization or RT-PCR positive Zika virus infection

Patient no.Country of originCountry of acquisitionGender/age (yr)aRT-PCR resultbNeutralization resultb1st sampleb2nd sampleb3rd sampleb4th sampleb
Time from onset (days)IgMIgGTime from onset (days)IgMIgGTime from onset (days)IgMIgGTime from onset (days)IgMIgG
1Czech RepublicMartiniqueF/38NegPos3PosNeg33EquPos
2Czech RepublicMartiniqueF/43NegPos5EquNeg59NegPos
3Czech RepublicDominican RepublicF/49PosPos5NegNeg10PosPos34PosPos
4Czech RepublicMartiniqueM/58PosPos14PosNeg27PosPos42PosPos
5Czech RepublicMartiniqueM/44NegPos13PosEqu38PosPos
6Czech RepublicMartiniqueM/41NegPos19PosPos34PosPos
7Czech RepublicMartiniqueF/42NDcPos31PosPos
8Czech Republic/SlovakiaBarbados, St. Vincent, St. LuciaM/33NegPos8PosEqu31PosPos
9Czech RepublicDominican RepublicF/64PosPos4PosNeg
10Czech RepublicGuadeloupeF/43PosPos3NegNeg7PosEqu15PosPos35PosPos
11Czech Republic/SlovakiaGuadeloupeM/41PosPos3NegNeg17PosPos
12Czech RepublicNicaraguaM/31Pos (semen)Pos11PosPos15PosPos61NegPos
13Czech Republic/IsraelMexicoM/26NegPos14PosNeg
14Czech RepublicNicaraguaF/31PosPos4NegNeg6PosNeg21EquPos
15Czech RepublicMexicoF/23NegPos26PosPos
16Czech Republic/FranceMartiniqueM/40PosEqu3NegNeg
17Czech RepublicMartiniqueM/7NDPos33NegPos
18Czech RepublicNicaraguaF/34NDPos182NegEqu
19Czech RepublicColombiaM/32NDPos∼360NegEqu
20Czech RepublicColombiaF/27NDPos∼360NegEqu
21Czech RepublicFrench PolynesiaM/65NDPos∼1,000NegPos
22BelgiumVenezuelaM/45PosND4NegNeg11dPosEqu
23BelgiumVenezuelaM/4PosND3dNegNeg
24BelgiumBrazilF/28PosND11dPosPos22PosPos
25BelgiumMartiniqueM/66NegPos20PosPos
26BelgiumMartiniqueF/66NegPos23PosPos
27BelgiumMartiniqueM/46NegPos19PosPos
28BelgiumSurinameF/20NegPos±80NegPos
29ChileBrazilF/25PosND1NegNeg
30ChileBrazilM/35PosND3NegNeg
31ChileVenezuelaF/17PosND4PosNeg
32ChileColombiaM/40PosND6PosNeg
33ChileDominican RepublicM/39PosND2NDND240NDNeg
34ChileCosta RicaM/25PosND2NegNeg
35ItalyThailandM/32NegPos5PosND39EquND110NegND
36ItalyItalyeF/30NegPos2PosND36PosND90NegND
37ItalyBrazilM/74NDPos40PosND
38ItalyHaitiM/34NDPos16PosND
39ItalyVenezuelaF/42PosPos7PosPos14PosPos49EquPos
40ItalyMartinique, GuadalupeF/34PosEqu4EquND
41ItalyDominican RepublicF/51PosPos7EquND
42ItalyVenezuelaF/32NegPos75NegND
43ItalyVenezuelaM/30NDPos79NegND
44ItalyBrazilF/37NDPos62NegND
45IsraelColombiaF/50PosPos5PosPos20NegPos
46IsraelColombiaF/32PosPos10PosPos53NegPos
47IsraelVietnamM/61PosNeg10PosNeg58NegNeg
48IsraelDominican RepublicM/30PosPos26PosPos46NegPos
49IsraelGuatemala, MexicoF/30PosNeg26NegNeg48NegNeg
50IsraelColombiaM/38NegPos34EquPos
51IsraelJamaicaM/23PosPos11PosEqu25PosPos49NegPos
52IsraelUSA (Miami)F/30PosPos8PosNeg
53IsraelCosta RicaM/27PosPos7PosNeg18EquEqu37NegPos
54IsraelMexicoM/26PosPos27EquPos52NegPos
55IsraelMexicoF/30PosPos12PosEqu15PosPos29EquPos50NegPos
56IsraelMexicoM/37PosPos5NegNeg14PosNeg28PosPos59NegNeg
57IsraelCosta RicaM/26PosPos6NegNeg11PosNeg
58IsraelCosta RicaM/20NegPos29PosPos
59IsraelMexico/CubaF/21PosND6NegNeg16PosPos
60GermanyMartiniqueM/56PosND3PosNeg8PosPos
61GermanyMartiniqueF/53PosND12EquNeg16NDPos
62GermanyGuadeloupeM/33PosND11PosNeg
63GermanyGuadeloupeF/29PosND6PosNeg
  • a F, female; M, male.

  • b Pos, positive; Neg, negative; Equ, equivocal.

  • c ND, not determined.

  • d These samples were also part of another study (7).

  • e This indicates an autochthonous transmission from patient 35 (15).